Glenmark Pharmaceuticals Board declares interim dividend
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2007, inter alia, has transacted the following:
1. Declared Interim dividend @ 70% on the Equity Share Capital of the Company for the financial year 2007-08.
2. Alloted 40,000 shares to the employees of the Company on exercise of options granted to them pursuant to ESOP 2003.
3. Approved conversion of Zero Coupon Foreign Currency Convertible Bonds amounting to US $
4,500,000 into 603,728 and 202,506 Equity shares at a price of Rs 253.11 and Rs 215.5985 per Share respectively of face value Re 1/- each out of US $ 70,000,000 Zero Coupon Foreign currency Convertible Bonds issued in 2005.
1. Declared Interim dividend @ 70% on the Equity Share Capital of the Company for the financial year 2007-08.
2. Alloted 40,000 shares to the employees of the Company on exercise of options granted to them pursuant to ESOP 2003.
3. Approved conversion of Zero Coupon Foreign Currency Convertible Bonds amounting to US $
4,500,000 into 603,728 and 202,506 Equity shares at a price of Rs 253.11 and Rs 215.5985 per Share respectively of face value Re 1/- each out of US $ 70,000,000 Zero Coupon Foreign currency Convertible Bonds issued in 2005.
0 Comments:
Post a Comment
<< Home